Akebia Therapeutics Inc. (AKBA)
NASDAQ · Healthcare
Akebia Therapeutics Inc. Long Term Debt 2014–2025
Akebia Therapeutics Inc. annual long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Akebia Therapeutics Inc. long term debt as of December 31, 2025: 48.3M, a 24.70% increase year-over-year.
- Akebia Therapeutics Inc. long term debt for 2025 were 48.3M, a 24.70% increase from 2024.
- Akebia Therapeutics Inc. long term debt for 2024 were 38.7M, a 11.56% increase from 2023.
- Akebia Therapeutics Inc. long term debt for 2023 were 34.7M, a 47.51% decrease from 2022.
- Akebia Therapeutics Inc. long term debt for 2022 were 66.1M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Akebia Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $48 |
| 2024 | $39 |
| 2023 | $35 |
| 2022 | $66 |
| 2021 | $98 |
| 2020 | $96 |
| 2019 | $76 |
Akebia Therapeutics Inc. Long Term Debt — FAQ
Akebia Therapeutics Inc. (AKBA) long term debt over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AKBA's long term debt history?
The chart and table above show Akebia Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.